Lv2
178 积分 2025-05-06 加入
CAR T-cell therapy in autoimmune diseases: where are we and where are we going
2小时前
待确认
CAR T-cell therapy in autoimmune diseases
2天前
已完结
Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
3天前
已完结
Tauroursodeoxycholic acid liposome alleviates DSS-induced ulcerative colitis through restoring intestinal barrier and gut microbiota
9天前
已完结
In vivo CAR engineering for immunotherapy
1个月前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
1个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
1个月前
已完结
T Cell–Redirecting Bispecific Antibodies in Multiple Myeloma: Optimal Dosing Schedule and Duration of Treatment
2个月前
已完结
T-cell-engaging bispecific antibodies in cancer
2个月前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2个月前
已完结
皖公网安备34019202002308
